Fulcrum Therapeutics, Inc.

CIK 1680581 · 527 filings in 45 form types · 2016-07-25 to 2026-11-16 · FULC

FiledFormCategory8-K items / descriptionAccession
2026-11-16 SCHEDULE 13G Ownership 0001104659-26-128728
2026-11-16 SCHEDULE 13G/A Ownership 0000935836-26-000588
2026-11-13 SCHEDULE 13G/A Ownership 0001104659-26-127211
2026-11-13 SCHEDULE 13G/A Ownership 0000919574-26-007765
2026-11-12 10-Q Financial reports 10-Q 0001193125-26-458453
2026-11-12 425 Registrations and prospectuses 0001193125-26-458402
2026-11-12 8-K Current reports 8.01 Other Events 0001193125-26-458387
2026-11-04 EFFECT Registrations and prospectuses 9999999995-26-003437
2026-11-04 424B3 Registrations and prospectuses 0001193125-26-447368
2026-11-03 S-4/A Registrations and prospectuses 0001193125-26-444432
2026-10-28 SCHEDULE 13G/A Ownership 0000070858-26-000532
2026-10-27 SCHEDULE 13G/A Ownership 0002052113-26-001118
2026-10-20 S-4/A Registrations and prospectuses 0001193125-26-426840
2026-10-08 S-4/A Registrations and prospectuses 0001193125-26-418056
2026-09-02 144 Ownership 0001193125-26-379476
2026-09-02 S-4 Registrations and prospectuses 0001193125-26-379106
2026-08-17 425 Registrations and prospectuses 0001193125-26-354107
2026-08-17 425 Registrations and prospectuses 0001193125-26-353282
2026-08-17 425 Registrations and prospectuses 0001193125-26-353280
2026-08-17 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001193125-26-353278
2026-08-14 SCHEDULE 13G/A Ownership 0001231919-26-000923
2026-08-14 SCHEDULE 13G/A Ownership 0001193125-26-352345
2026-08-14 SCHEDULE 13G Ownership 0001104659-26-097278
2026-08-14 SCHEDULE 13G/A Ownership 0000919574-26-005528
2026-08-10 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0001193125-26-341385
2026-08-03 SCHEDULE 13G Ownership 0000070858-26-000396
2026-07-30 10-Q Financial reports 10-Q 0001193125-26-326098
2026-07-28 SCHEDULE 13G/A Ownership 0002012383-26-002576
2026-07-20 4 Ownership 0001178579-26-000016
2026-07-17 SCHEDULE 13G Ownership 0002052113-26-000745
2026-07-15 SCHEDULE 13G/A Ownership 0001214659-26-008613
2026-07-15 4 Ownership 0001178579-26-000014
2026-07-15 3 Ownership 0001178579-26-000013
2026-07-02 4 Ownership 0001193125-26-294703
2026-07-02 4 Ownership 0001193125-26-294699
2026-07-02 4 Ownership 0001193125-26-294697
2026-07-02 4 Ownership 0001193125-26-294692
2026-07-02 4 Ownership 0001193125-26-294691
2026-07-02 4 Ownership 0001193125-26-294690
2026-07-02 4 Ownership 0001193125-26-294683
2026-07-02 4 Ownership 0001193125-26-294680
2026-06-30 4 Ownership 0001193125-26-290622
2026-06-26 144 Ownership 0001950047-26-006549
2026-06-25 8-K Current reports 5.07 Submission of Matters to a Vote of Security Holders 0001193125-26-282873
2026-06-25 SCHEDULE 13G Ownership 0000935836-26-000331
2026-06-25 SCHEDULE 13G Ownership 0000935836-26-000330
2026-06-11 8-K Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0001193125-26-267659
2026-06-10 SCHEDULE 13G Ownership 0001214659-26-007338
2026-06-04 8-K Current reports 2.05 Costs Associated with Exit or Disposal Activities; 8.01 Other Events 0001193125-26-257376
2026-06-01 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001193125-26-251394